The Center of Genetic Engineering and Biotechnology (CIGB) is pleased to announce the 5th International Symposium CANCER 2025 to be held in Varadero, Cuba, from July 3rd to 7th, 2025.

This field-day event will bring together basic scientists, medicinal chemists, pharmacologists, biotechnologists, clinical investigators, and other allied professionals from around the world, interested in the fields of cancer pathogenesis and new targeted therapies development. The meeting will be an excellent opportunity to expose the translational nature of modern biomedical and pharmaceutical research. Within the event, we will dedicate special attention to antiangiogenic passive and active immunotherapeutic strategies and also to the combinations emerging in this field, particularly with checkpoint inhibitors.

· Cancer Immunotherapy with a focus on angiogenesis and checkpoint inhibitors

· Drug combination with checkpoint inhibitors

· Cancer Targeted Therapy

· CAR-T Cell Therapy

· Tumor Microenvironment

· Preclinical and early-phase clinical development

· Clinical trials phase II-IV design and results

· Soluble and cellular Biomarkers of Response and Prognosis

03 July 2025

07 July 2025

Iberostar Selection Varadero Resort

Varadero

Matanzas, Cuba + Google Map

Monica Bequet Romero, PhD. Head of the Scientific Committee, Cancer 2025. Pharmaceuticals Department, Biomedical Research, CIGB

Monica Bequet Romero, PhD. Head of the Scientific Committee, Cancer 2025. Pharmaceuticals Department, Biomedical Research, CIGB

Julio Raúl Fernández, PhD, Head of Pharmaceutics Department, Leader Antitumor Therapy